C4A and amyotrophic lateral sclerosis: Additionally, although there is strong evidence of complement upregulation in ALS, normal C3 and C4 levels were also observed in patients with ALS (25, 28), and the specific genetic deletion of C3 and C4 in ALS mouse models did not show any beneficial effects on the disease progression (12, 29).